Genenta Science
GNTA
2 hedge funds and large institutions have $17K invested in Genenta Science in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
33% less funds holding
Funds holding: 3 → 2 (-1)
37% less capital invested
Capital invested by funds: $27K → $17K (-$10K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $15K | +$1.19K | +200 | +7% |
|
2
Morgan Stanley
New York
| $2K | – | – | – |
|
|
3
Bank of America
Charlotte,
North Carolina
| – | -$3K | -381 | Closed |
|
GNTA Hedge Fund Activity: Q3 2022 in Review
2 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q3 2022, worth a combined $17K — down 37% from $27K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GNTA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $1.19K. The largest seller was Bank of America, exiting entirely with an estimated $3K sold.
- 2 institutional investors held Genenta Science (GNTA) as of Q3 2022, down from 3 in Q2 2022.
- Funds reported $17K of Genenta Science stock for Q3 2022, down 37% quarter-over-quarter.
- 0 funds opened new Genenta Science positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Genenta Science buyer in Q3 2022 was UBS Group, an estimated $1.19K added.
- The largest Genenta Science seller in Q3 2022 was Bank of America, an estimated $3K sold.
Based on aggregated 13F filings for Q3 2022.